Translational Development Acquisition (TDACW) Accounts Payables (2023 - 2026)

Translational Development Acquisition (TDACW) has reported Accounts Payables for 4 consecutive years, with $484788.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Accounts Payables rose 197.56% year-over-year to $484788.0; the trailing twelve-month figure through Jun 2026 stood at $484788.0 (up 197.56% YoY), and the FY2025 full-year result was $162311.0, up 902.6% from the prior year.
• Accounts Payables rose to $484788.0 in Q2 2026 per TDACW's latest filing, from $224323.0 in the prior quarter.
• Across five years, Accounts Payables topped out at $484788.0 in Q2 2026 and bottomed at $1252.0 in Q4 2023.
• Historically, Accounts Payables has averaged $181042.9 across 4 years, with a median of $167001.5 in 2025.
• The sharpest annual moves came in 2024 and 2026: Accounts Payables jumped 1193.05% in 2024, then declined 0.51% in 2026.
• Over 4 years, Accounts Payables stood at $1252.0 in 2023, then surged by 1193.05% to $16189.0 in 2024, then surged by 902.6% to $162311.0 in 2025, then surged by 198.68% to $484788.0 in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $484788.0, $224323.0, and $162311.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.